Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products-Reference-Cited by-同舟云学术

Two new synthetic cannabinoids, AM-2201 benzimidazole analog (FUBIMINA) and (4-methylpiperazin-1-yl)(1-pentyl-1H-indol-3-yl)methanone (MEPIRAPIM), and three phenethylamine derivatives, 25H-NBOMe 3,4,5-trimethoxybenzyl analog, 25B-NBOMe, and 2C-N-NBOMe, identified in illegal products

Published:2013-11-26 Issue:1 Volume:32 Page:105-115
ISSN:1860-8965
Container-title:Forensic Toxicology
language:en
Short-container-title:Forensic Toxicol

Author:

Uchiyama Nahoko,Shimokawa Yoshihiko,Matsuda Satoru,Kawamura Maiko,Kikura-Hanajiri Ruri,Goda Yukihiro

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry (medical),Toxicology,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s11419-013-0217-2.pdf

Reference17 articles.

1. UNODC (2013) Global SMART update 2013—vol 10, September 2013. http://www.unodc.org/documents/scientific/Global_SMART_Update_10_web.pdf . Accessed Sept 2013

2. UNODC (2013) The challenge of new psychoactive substances. A report from the global SMART programme, March 2013. http://www.unodc.org/documents/scientific/NPS_2013_SMART.pdf . Accessed Sept 2013

3. EMCDDA (2013) EMCDDA/Europol, 2005/387/JHA, EMCDDA-Europol 2012 annual report on the implementation of council decision, Lisbon, May 2013. http://www.emcdda.europa.eu/publications/implementation-reports/2012 . Accessed May 2013

4. Kikura-Hanajiri R, Uchiyama N, Kawamura M, Goda Y (2013) Changes in the prevalence of synthetic cannabinoids and cathinone derivatives in Japan until early 2012. Forensic Toxicol 31:44–53

5. Kikura-Hanajiri R, Uchiyama N, Kawamura M, Ogata J, Goda Y (2013) Prevalence of new designer drugs and their legal status in Japan. Yakugaku Zasshi 133:31–40 (in Japanese with English abstract)

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mepirapim, a novel synthetic cannabinoid, induces Parkinson’s disease-related behaviors by causing maladaptation of the dopamine system in the brain;Archives of Toxicology;2022-11-10

2. Mepirapim, a Novel Synthetic Cannabinoid, Induces Addiction-Related Behaviors through Neurochemical Maladaptation in the Brain of Rodents;Pharmaceuticals;2022-06-03

3. Putative Synthetic Cannabinoids MEPIRAPIM, 5F-BEPIRAPIM (NNL-2), and Their Analogues Are T-Type Calcium Channel (Ca_V3) Inhibitors;ACS Chemical Neuroscience;2022-04-20

4. Analytical Methods for Herbal Products Containing Synthetic Cannabinoids: A Review;Forensic Chemistry;2022-03

5. Determination of in vitro human whole blood-to-plasma ratio of THJ-018 utilizing gas chromatography–Mass spectrometry;Indian Journal of Pharmacology;2021